The FDA’s Accelerated Approval Program began in 1992, and it is designed to allow drugs that treat serious conditions to be approved earlier, particularly if this earlier approval fills an unmet need when it comes to treating that condition. For example, if there is a disease that doesn’t have any drugs available to help slow the progression of disease, a promising drug that might slow disease progression could be approved via the Accelerated Approval Program.Â





